Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Mezzion Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,574,860	924,369	1,153,908	347,646	1,932,235	1,563,338
Market Cap Growth	161.59%	-19.89%	231.92%	-82.01%	23.60%	-6.13%
Enterprise Value	2,557,293	891,105	1,093,258	314,521	1,903,261	1,542,499
Last Close Price	84800.00	30850.00	39000.00	13000.00	72366.67	58600.00
PS Ratio	332.26	107.34	36.38	11.31	72.49	54.60
PB Ratio	68.95	20.07	18.78	13.25	30.77	27.52
P/TBV Ratio	72.07	20.80	19.29	14.12	31.59	28.33
EV/Sales Ratio	-	103.48	34.47	10.24	71.41	53.87
EV/FCF Ratio	-226.63	-	-	-	-	-
Debt / Equity Ratio	0.29	0.04	0.04	0.04	0.07	0.09
Asset Turnover	0.10	0.10	0.43	0.45	0.33	0.43
Inventory Turnover	1.15	1.20	3.82	3.01	2.44	3.26
Quick Ratio	0.60	1.12	2.12	1.35	2.72	3.35
Current Ratio	0.88	1.57	2.51	1.76	3.47	3.91
Return on Equity (ROE)	-48.05%	-36.23%	-29.03%	-81.54%	-22.75%	-27.85%
Return on Assets (ROA)	-12.10%	-10.76%	-12.39%	-21.14%	-13.16%	-7.00%
Return on Capital (ROIC)	-18.95%	-16.05%	-19.90%	-30.89%	-16.27%	-8.69%
Return on Capital Employed (ROCE)	-40.80%	-30.20%	-23.20%	-83.50%	-25.70%	-12.50%
Earnings Yield	-0.85%	-2.11%	-1.10%	-10.44%	-0.70%	-0.89%
FCF Yield	-0.44%	-2.06%	-1.00%	-3.69%	-0.80%	-0.52%
Buyback Yield / Dilution	-1.16%	-5.62%	-5.63%	-0.17%	-2.63%	-0.11%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.